Analysis of the p16 gene (CDKN2) as a candidate for the chromosome 9p melanoma susceptibility locus
10.1038/ng0994-22
Crossref journal-article
Springer Science and Business Media LLC
Nature Genetics (297)
Bibliography

Kamb, A., Shattuck-Eidens, D., Eeles, R., Liu, Q., Gruis, N. A., Ding, W., Hussey, C., Tran, T., Miki, Y., Weaver-Feldhaus, J., McClure, M., Aitken, J. F., Anderson, D. E., Bergman, W., Frants, R., Goldgar, D. E., Green, A., MacLennan, R., Martin, N. G., … Cannon-Albright, L. A. (1994). Analysis of the p16 gene (CDKN2) as a candidate for the chromosome 9p melanoma susceptibility locus. Nature Genetics, 8(1), 22–26.

Authors 24
  1. A. Kamb (first)
  2. D. Shattuck-Eidens (additional)
  3. R. Eeles (additional)
  4. Q. Liu (additional)
  5. N. A. Gruis (additional)
  6. W. Ding (additional)
  7. C. Hussey (additional)
  8. T. Tran (additional)
  9. Y. Miki (additional)
  10. J. Weaver-Feldhaus (additional)
  11. M. McClure (additional)
  12. J. F. Aitken (additional)
  13. D. E. Anderson (additional)
  14. W. Bergman (additional)
  15. R. Frants (additional)
  16. D. E. Goldgar (additional)
  17. A. Green (additional)
  18. R. MacLennan (additional)
  19. N. G. Martin (additional)
  20. L. J. Meyer (additional)
  21. P. Youl (additional)
  22. J. J. Zone (additional)
  23. M. H. Skolnick (additional)
  24. L. A. Cannon-Albright (additional)
References 32 Referenced 626
  1. Cannon-Albright, L.A. et al. Assignment of a locus for familial melanoma MLM, to chromosome 9p13–22. Science 258, 1148–1152 (1992). (10.1126/science.1439824) / Science by LA Cannon-Albright (1992)
  2. Nancarrow, D.J. et al. Confirmation of chromosome 9p linkage in familial melanoma. Am. J. hum. Genet. 53, 936–942 (1993). / Am. J. hum. Genet. by DJ Nancarrow (1993)
  3. Gruis, N.A. et al. Linkage analysis in Dutch familial atypical multiple mole-melanoma (FAMMM) syndrome families. Effect on naevus count. Melanoma Res. 3, 271–277 (1993). / Melanoma Res. by NA Gruis (1993)
  4. Goldstein, A.M. et al. Linkage of cutaneous malignant melanoma/dysplastic nevi to chromosome 9p, and evidence for genetic heterogeneity. Am. J. hum. Genet. 54, 489–496 (1994). / Am. J. hum. Genet. by AM Goldstein (1994)
  5. Cannon-Albright, L.A. et al. Localization of the 9p melanoma susceptibility locus to a 2cM region between D9S736 and D9S171. Genomics (in the press).
  6. Knudson, A.G. Mutation and cancer: statistical study of Retinoblastoma. Proc. natn. Acad. Sci. U.S.A. 68, 820–823 (1971). (10.1073/pnas.68.4.820) / Proc. natn. Acad. Sci. U.S.A. by AG Knudson (1971)
  7. Weaver-Feldhaus, J. et al. Localization of a putative tumor suppressor gene using homozygous deletion breakpoints in melanomas. Proc. natn. Acad. Sci. U.S.A. 91, 7563–7567 (1994). (10.1073/pnas.91.16.7563) / Proc. natn. Acad. Sci. U.S.A. by J Weaver-Feldhaus (1994)
  8. Kamb, A. et al. A cell cycle regulator potentially involved in genesis of many tumor types. Science 264, 436 (1994). (10.1126/science.8153634) / Science by A Kamb (1994)
  9. Nobori, T. et al. Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers. Nature 368, 753 (1994). (10.1038/368753a0) / Nature by T Nobori (1994)
  10. Serrano, M., Hannon, G.J. & Beach, D. A new regulatory motif in cell cycle control causing specific inhibition of cyclin D/CDK4. Nature 366, 704, (1993). (10.1038/366704a0) / Nature by M Serrano (1993)
  11. Sherr, C.J. Mammalian G1 cyclins. Cell 73, 1059–1065 (1993). (10.1016/0092-8674(93)90636-5) / Cell by CJ Sherr (1993)
  12. Anderson, D.E. & Badzioch, M.D. Hereditary cutaneous malignant melanoma: A 20-year family update. Anticancer Res. 11, 433–438 (1991). / Anticancer Res. by DE Anderson (1991)
  13. Aitken, J.F. et al. Heterogeneity of melanoma risk in families of melanoma patients. Am. J. Epidem. (in the press).
  14. Fountain, J.W. et al. Homozygous deletions within human chromosome band 9p21 in melanoma. Proc. natn. Acad. Sci. U.S.A. 89, 10557–10561 (1992). (10.1073/pnas.89.21.10557) / Proc. natn. Acad. Sci. U.S.A. by JW Fountain (1992)
  15. Knudson, A.G. All in the (cancer) family. Nature Genet. 5, 103–104 (1993). (10.1038/ng1093-103) / Nature Genet. by AG Knudson (1993)
  16. Harris, C.C. p53: at the cross roads of molecular carcinogenesis and risk assessment. Science 262, 1980 (1993). (10.1126/science.8266092) / Science by CC Harris (1993)
  17. Goldstein, A.M. et al. Further evidence for a locus for cutaneous malignant melanoma-dysplastic nevus (CMM/DN) on chromosome 1p, and evidence for genetic heterogeneity. Am. J. hum. Genet. 52, 537–550 (1993). / Am. J. hum. Genet. by AM Goldstein (1993)
  18. Bale, S.J. et al. Mapping the gene for hereditary cutaneous malignant melanoma-dysplastic naevus to chromosome 1p. New Engl. J. Med. 320, 1367–1372 (1989). (10.1056/NEJM198905253202102) / New Engl. J. Med. by SJ Bale (1989)
  19. Cannon-Albright, L.A. et al. Evidence against the reported linkage to the cutaneous melanoma-dysplastic naevus syndrome locus to chromosome 1p36. Am. J. hum. Genet. 46, 912–918 (1990). / Am. J. hum. Genet. by LA Cannon-Albright (1990)
  20. Gruis, N.A., Bergman, W. & Frants, R.R. Locus for susceptibility to melanoma on chromosome 1p. New Engl. J. Med. 322, 853–854 (1990). / New Engl. J. Med. by NA Gruis (1990)
  21. Kefford, R.F., Salmon, J., Shaw, H.M., Donald, J.A. & McCarthy, W.H. Hereditary melanoma in Australia: variable association with dysplastic naevi and absence of genetic linkage to chromosome 1p. Cancer Genet. Cytogenet. 51, 45–55 (1991). (10.1016/0165-4608(91)90007-H) / Cancer Genet. Cytogenet. by RF Kefford (1991)
  22. Nancarrow, D.J. et al. Exclusion of the familial melanoma locus (MLM) from the PND/D1S47 and LMYC regions of chromosome arm 1p in 7 Australian pedigrees. Genomics 12, 18–25 (1992). (10.1016/0888-7543(92)90401-D) / Genomics by DJ Nancarrow (1992)
  23. van Haeringen, A. et al. Exclusion of the dysplastic naevus syndrome (DNS) locus from the short arm of chromosome 1 by linkage studies in Dutch families. Genomics 5, 61–64 (1989). (10.1016/0888-7543(89)90086-4) / Genomics by A van Haeringen (1989)
  24. Cairns, P. et al. Rate of p16 (MTS1) mutations found in primary tumors with 9p loss. Science 265, 415–416 (1994). (10.1126/science.8023167) / Science by P Cairns (1994)
  25. Spruck, C.H. III et al. p16 gene in uncultured tumours. Nature 370, 183–184 (1994). (10.1038/370183a0) / Nature by CH Spruck III (1994)
  26. Takahiro, M. et al. Frequent somatic mutation of the MTS1/CDK4I (multiple tumor suppressor/cyclin-dependent kinase 4 inhibitor) gene in esophageal squamous cell carcinoma. Cancer Res. 54, 3396–3397 (1994). / Cancer Res. by M Takahiro (1994)
  27. Kamb, A. et al. Response to rate of p16 (MTS1) “Rate of mutations found in primary tumors with 9p loss”. Science 265, 416–417 (1994). (10.1126/science.265.5170.416) / Science by A Kamb (1994)
  28. Bergman, W., Palan, A. & Went, L.N. Clinical and genetic studies in six Dutch kindreds with Dysplastic Naevus Syndrome. Ann. hum. Genet. 50, 249–258 (1986). (10.1111/j.1469-1809.1986.tb01046.x) / Ann. hum. Genet. by W Bergman (1986)
  29. Cai, S.P. et al. Two novel beta-thalassemia mutations in the 5′ and 3′ noncoding regions of the beta-globin gene. Blood 79, 1342–1346 (1992). (10.1182/blood.V79.5.1342.1342) / Blood by SP Cai (1992)
  30. Randall, T. Triplet repeat mutations: amplification within pedigrees generates three human diseases. J. Am. med. Assoc. 269, 558&562 (1993). (10.1001/jama.1993.03500050016004) / J. Am. med. Assoc. by T Randall (1993)
  31. Sambrook, J., Fritsch, E.F. & Maniatis, T. Molecular cloning: a laboratory manual (Cold Spring Harbor Laboratory Press, Plainview, New York, 1989). / Molecular cloning: a laboratory manual by J Sambrook (1989)
  32. Miki, Y. et al. Disruption of the APC gene by a retrotransposal insertion of L1 sequence in a colon cancer. Cancer Res. 52, 643–645 (1992). / Cancer Res. by Y Miki (1992)
Dates
Type When
Created 21 years ago (Aug. 18, 2004, 4:50 p.m.)
Deposited 2 years, 3 months ago (May 18, 2023, 4:57 p.m.)
Indexed 3 weeks, 1 day ago (Aug. 2, 2025, 1:21 a.m.)
Issued 30 years, 11 months ago (Sept. 1, 1994)
Published 30 years, 11 months ago (Sept. 1, 1994)
Published Print 30 years, 11 months ago (Sept. 1, 1994)
Funders 0

None

@article{Kamb_1994, title={Analysis of the p16 gene (CDKN2) as a candidate for the chromosome 9p melanoma susceptibility locus}, volume={8}, ISSN={1546-1718}, url={http://dx.doi.org/10.1038/ng0994-22}, DOI={10.1038/ng0994-22}, number={1}, journal={Nature Genetics}, publisher={Springer Science and Business Media LLC}, author={Kamb, A. and Shattuck-Eidens, D. and Eeles, R. and Liu, Q. and Gruis, N. A. and Ding, W. and Hussey, C. and Tran, T. and Miki, Y. and Weaver-Feldhaus, J. and McClure, M. and Aitken, J. F. and Anderson, D. E. and Bergman, W. and Frants, R. and Goldgar, D. E. and Green, A. and MacLennan, R. and Martin, N. G. and Meyer, L. J. and Youl, P. and Zone, J. J. and Skolnick, M. H. and Cannon-Albright, L. A.}, year={1994}, month=sep, pages={22–26} }